Nutraceutical Excipients Market

How big is Nutraceutical Excipients Market in 2026?

USD 3.1 Billion in 2026 and USD 6.2 Billion by 2036 at a 7.0% CAGR.

Sales of nutraceutical excipients are estimated to grow at 7.0% from USD 3.1 Billion in 2026 to USD 6.2 Billion by 2036. The market stood at USD 2.9 Billion in 2025. Demand rises when supplement manufacturers move from a promising active ingredient to a dosage form that can be blended, compressed, filled, coated, stored, and released consistently. Roquette used Vitafoods Europe 2026 to position its expanded consumer-healthcare portfolio across oral formats, showing how suppliers are competing around formulation support rather than ingredient supply alone.

The growth mechanism differs by country. US reformulation work has accelerated around the FDA phaseout of FD&C Red No. 3 in foods, including dietary supplements, while the UK Food Standards Agency now describes supplements across pills, gummies, capsules, and powders in its 2026 guidance. These conditions widen the commercial brief for excipients because a formulation must satisfy both the manufacturing process and the destination market. The same pressure is visible across the wider dietary supplement market, where dosage form and label requirements shape repeat purchases.

Key Takeaways of Nutraceutical Excipients Market

• Demand mechanism: Supplement brands buy excipients when a dosage-form problem moves from formulation work into repeat commercial production.
• Leading Product Type: Fillers and Diluents hold 25.0% in 2026 because building a workable matrix remains a basic requirement in tablets and capsules.
• Dosage Form: Tablets create a dense excipient requirement across filling, binding, disintegration, lubrication, and coating without implying a separate market-share estimate.
• Reformulation pressure: US removal of FD&C Red No. 3 from food uses creates a current reason to revisit color and coating systems before the January 2027 deadline.
• Country signal: UK and USA lead the profiled country growth rates at 9.0% and 8.0%, while local food and supplement rules continue to shape material selection.
• Notable companies include Roquette Freres, J. Rettenmaier & Sohne GmbH (JRS), Ashland Inc., International Flavors & Fragrances Inc. (IFF), and Colorcon Inc.

Analyst Perspective

“Nutraceutical excipient demand is created at the point where a supplement concept has to become a stable, repeatable dosage form. Suppliers gain repeat business when the selected grade shortens formulation work, protects the active, and stays compatible with the destination market.”

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the Nutraceutical Excipients Market segmented?

The Nutraceutical Excipients Market is segmented by Product Type, Dosage Form, and Region.

By product type, it includes fillers and diluents, MCC, coating agents, crospovidone, flavoring agents, HPMC, croscarmellose, lubricants, others, and HPC. By dosage form, it covers tablets, capsules, gummies and chewables, powders and sachets, softgels, and liquids. Product type describes the excipient purchased, while dosage form reflects the manufacturing environment in which the excipient performs.

Why do Fillers and Diluents lead demand within the Product Type category?

Fillers and Diluents create the physical matrix around nutraceutical actives and therefore influence blend flow, tablet weight, hardness, and downstream coating behavior. Roquette’s 2025 CPHI portfolio highlighted mannitol as a non-hygroscopic filler alongside AVICEL MCC and other solid-dose excipients. MCC remains separately tracked within the market even where its functional role overlaps with broader filler systems. The distinction matters because buyers compare a named material such as microcrystalline cellulose against composite or alternative filler systems on handling, compression, moisture, and cost-in-use.

• Fillers and Diluents account for 25.0% of Product Type demand in 2026, making them the largest approved Product Type segment.
• Selection is formulation-specific: moisture-sensitive actives can favor less hygroscopic grades, while direct-compression programs place more weight on flow and compactability.

Why do Tablets matter within the Dosage Form category?

Tablets make several excipient functions interact in one manufacturing sequence. A direct-compression product can require a filler, binder, disintegrant, lubricant, glidant, and coating system to work together without creating sticking, friability, slow disintegration, or poor appearance. JRS Pharma’s current PROSOLV NX is designed as a pre-lubricated composite for direct-compression nutraceutical applications, illustrating the commercial value of reducing formulation steps. Capsule programs shift attention toward powder flow and compatibility with capsule filling machines, while gelling, flavor, and color systems become more important in nutraceutical gummies.

• Tablets concentrate multiple excipient functions in one process and therefore create a strong requirement for compatibility across the full formulation system.
• Capsules, gummies and chewables, powders and sachets, softgels, and liquids each shift the formulation brief toward different flow, sensory, protection, or dispersion requirements.

What are the drivers, restraints and opportunities in the Nutraceutical Excipients Market?

Reformulation creates new excipient briefs, cross-market qualification slows material switching, and dosage-form specialization opens higher-value formulation opportunities.

• Driver: Regulatory reformulation creates immediate work for color, coating, and finishing systems.
• Restraint: A substitute excipient can require new process, quality, and destination-market checks before repeat purchasing begins.
• Opportunity: Multifunctional and dosage-form-specific systems can reduce manufacturing steps or protect sensitive actives.

Reformulation keeps coating and finishing specifications active

The FDA revoked authorization for FD&C Red No. 3 in food on January 15, 2025 and later urged manufacturers to accelerate reformulation ahead of the January 15, 2027 food deadline. Dietary supplements are included within the affected food uses. This creates a defined formulation task for products that relied on the colorant: the replacement system must meet appearance goals while remaining workable on the existing coating process. Colorcon’s current Nutrafinish portfolio includes titanium-dioxide-free, mineral-free, moisture-protection, and easy-swallow systems for nutritional products, illustrating how suppliers can compete through complete finishing solutions rather than isolated pigments.

Cross-market qualification slows apparently simple substitutions

A material that works on a tablet press can still create a destination-market question. The UK Food Standards Agency’s 2026 guidance treats pills, gummies, capsules, and powders as food-supplement dose forms, while Japan’s Consumer Affairs Agency updated its Foods with Function Claims guidance in 2025 and South Korea revised health functional food rules in 2026. Germany follows EU food-additive conditions. The commercial implication is straightforward: formulation teams need a material that performs in the process and remains appropriate for the intended supplement category. That additional review makes supplier switching more demanding than comparing unit prices.

Dosage-form specialization creates a higher-value formulation opportunity

Excipient suppliers can create more value when one system removes formulation steps or solves a format-specific problem. JRS Pharma positions PROSOLV NX as an all-in-one composite for direct-compression nutraceutical tablets, and Ashland’s June 2026 India investment is designed to add regional Aquarius tablet-coating capacity for pharmaceutical and nutraceutical customers. These moves sit inside the broader dietary supplement excipients and delivery systems opportunity, where manufacturers increasingly compare the total work needed to reach a stable commercial dose rather than the price of one inactive ingredient.

Which country CAGRs are profiled in the Nutraceutical Excipients Market?

Country CAGRs cover 2026 to 2036.

Country	CAGR
UK	9.0%
USA	8.0%
Japan	7.0%
South Korea	6.0%
Germany	5.0%

How do country-level CAGRs compare in the Nutraceutical Excipients Market?

UK and USA form the higher-growth pair at 9.0% and 8.0%. Japan matches the overall market rate at 7.0%, followed by South Korea at 6.0% and Germany at 5.0%. The 4.0 percentage-point spread describes forecast growth, while the purchasing mechanism in each country depends on its own supplement rules, formulation practices, and manufacturing base.

• UK: Current Food Standards Agency guidance recognizes supplements across pills, gummies, capsules, and powders, keeping dosage-form design close to food-safety and labeling requirements.
• USA: The FD&C Red No. 3 phaseout creates a current reformulation cycle for affected supplement colors and coatings before January 2027.
• Japan: Revised Foods with Function Claims guidance keeps manufacturing documentation and product specifications important for covered tablet and capsule products.
• South Korea: Updated 2026 health functional food rules and personalized-supplement guidance increase attention to standardized ingredients and finished-dose handling.
• Germany: EU food-additive conditions shape which colors and other excipient materials are suitable for supplement formulations sold as foods.

Country-wise Analysis

• UK is forecast to expand at 9.0% CAGR from 2026 to 2036. The Food Standards Agency published new food-supplement guidance in June 2026 and describes products in dose forms including pills, gummies, capsules, and powders. That breadth matters to excipient suppliers because each format creates a different manufacturing brief. A coating supplier competes on tablet finish and process efficiency, while a gummy formulation requires different texturizing and sensory support. The commercial opportunity is strongest where a supplier can connect its ingredient specification to the exact dose form and intended food-supplement use.
• USA is projected to grow at 8.0% CAGR from 2026 to 2036. The FDA’s 2025 withdrawal of FD&C Red No. 3 authorization for food, including dietary supplements, creates a near-term reformulation requirement ahead of January 15, 2027. Brands using affected color systems need alternatives that preserve appearance without destabilizing the coating process or label position. This gives coating and color-system suppliers a concrete route into existing products, but repeat orders depend on successful scale-up rather than on regulatory change alone.
• Japan is forecast at 7.0% CAGR from 2026 to 2036. The Consumer Affairs Agency revised guidance for Foods with Function Claims in October 2025, building on manufacturing requirements for certain tablet and capsule products using natural extracts and related ingredients. For excipient suppliers, controlled material specifications and change management become commercially important when customers operate inside a formal notification framework. The opportunity is strongest for grades that are easy to document and reproduce through commercial production.
• South Korea is projected to record 6.0% CAGR from 2026 to 2036. MFDS updated regulations on functional ingredients and standards in 2026 and issued a revised guide to personalized health functional foods in August 2026. Personalized handling does not create a new excipient category, but it increases the value of durable tablets, capsules, and other standardized units that can move through repeated selection and packing steps. Suppliers can benefit where their material supports consistent finished-dose quality.
• Germany is forecast at 5.0% CAGR from 2026 to 2036. Food supplements follow EU food-additive rules, so coating and flavoring choices must be appropriate for food use rather than borrowed automatically from pharmaceutical formulations. The European Commission’s current additive database makes conditions of use a practical formulation reference. Suppliers that offer food-suitable alternatives with clear composition and processing guidance can reduce the work required when brands refresh colors, coatings, or sensory systems.

Who are the notable companies in the Nutraceutical Excipients Market?

Roquette Freres, J. Rettenmaier & Sohne GmbH (JRS), Ashland Inc., International Flavors & Fragrances Inc. (IFF), and Colorcon Inc. are the notable companies profiled in this market.

Competition spans core tablet matrices, formulated coatings, and sensory systems. Roquette expanded its excipient platform through the May 2025 acquisition of IFF Pharma Solutions and presented an integrated health and pharma portfolio at CPHI 2025 and Vitafoods Europe 2026. JRS Pharma maintains a current portfolio of fillers, binders, superdisintegrants, lubricants, carriers, and nutraceutical composites. Ashland is adding tablet-coating capacity in India, while Colorcon opened a film-coating plant in Malaysia in July 2025. IFF remains relevant to the Flavoring Agent category through current taste-modulation capabilities rather than through the divested Pharma Solutions platform.

• Core solid-dose excipients: Roquette Freres and J. Rettenmaier & Sohne GmbH (JRS).
• Coating and protection systems: Ashland Inc. and Colorcon Inc.
• Flavoring and taste modulation: International Flavors & Fragrances Inc. (IFF).

Competitive Benchmarking: Nutraceutical Excipients Market

Company	Core solid-dose excipients	Coating / protection	Sensory / formulation support	Geographic reach
Roquette Freres	High	High	Medium	Global health and pharma network, with expanded formulation and consumer-healthcare capabilities after the IFF Pharma Solutions acquisition.
J. Rettenmaier & Sohne GmbH (JRS)	High	Medium	High	Global excipient business with technical support across multiple regions.
Ashland Inc.	Medium	High	Medium	Tablet-coating manufacturing in the USA, China and Brazil, with an India facility under development.
International Flavors & Fragrances Inc. (IFF)	Unscored	Unscored	High	Global taste and flavor network supporting sensory formulation work.
Colorcon Inc.	Unscored	High	High	Global coating network with Asia-Pacific manufacturing from the Johor, Malaysia facility.

Scoring basis: Core solid-dose excipients is High for a broad current portfolio spanning several matrix functions and Medium for a narrower relevant role. Coating / protection is High for dedicated formulated coating or barrier systems and Medium for a more limited offering. Sensory / formulation support is High for dedicated application or taste-development capability and Medium for a narrower documented role. Unscored indicates that the benchmark does not rate that capability for the company. These ratings describe capability breadth, not market share.

Key Developments in the Nutraceutical Excipients Market

• In June 2026, Ashland Inc. broke ground on an Aquarius tablet-coatings manufacturing facility in Ambernath, India. The planned site is intended to serve pharmaceutical and nutraceutical customers across India and the wider Asia-Pacific region once operational.
• In July 2025, Colorcon Inc. opened its film-coating manufacturing facility in Johor, Malaysia. The site became a regional production hub for film coatings used by pharmaceutical and nutraceutical manufacturers across Asia-Pacific.
• In May 2025, Roquette Freres completed its acquisition of IFF Pharma Solutions. The transaction expanded Roquette’s excipient and drug-delivery portfolio and changed ownership of the former IFF Pharma Solutions assets.

Key Players in the Nutraceutical Excipients Market

Core tablet matrix and disintegration

• Roquette Freres
• J. Rettenmaier & Sohne GmbH (JRS)

Functional polymer and coating systems

• Ashland Inc.
• Colorcon Inc.

Flavoring and taste modulation

• International Flavors & Fragrances Inc. (IFF)

Nutraceutical Excipients Market - Report Scope

Coverage field	Report scope
Market breakdown	Product Type; Dosage Form; Region.
Quantitative Units	Revenue in USD Billion and CAGR in %.
Market Definition	Revenue from excipient materials and formulated excipient systems sold for nutraceutical use across the stated Product Type and Dosage Form categories. Dietary actives and downstream finished-product revenue are excluded, as are packaging, equipment, and separately charged manufacturing or advisory services.
Regions Covered	North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa.
Countries Covered	UK; USA; Japan; South Korea; Germany.
Key Companies Profiled	Roquette Freres; J. Rettenmaier & Sohne GmbH (JRS); Ashland Inc.; International Flavors & Fragrances Inc. (IFF); Colorcon Inc.
Forecast Period	2026 to 2036

Nutraceutical Excipients Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, distributors, contract manufacturers, supplement brands, procurement teams and formulation specialists. Interviews examined purchasing decisions, product qualification, switching barriers, pricing considerations and technical-support requirements.
Desk Research	Desk research covered regulatory publications, industry associations, technical literature, company filings, current product documentation and official corporate announcements. Sources were reviewed for relevance to the defined market scope and forecast period.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, Product Type structure, country-level demand conditions, company participation and the commercial effect of formulation, regulatory and supply changes.
Data Validation	Estimates were checked against multiple independent indicators and reconciled across segments and countries to maintain a consistent market boundary and avoid overlapping revenue.

Nutraceutical Excipients Market by Segments

Nutraceutical Excipients Market segmented by Product Type:

• Fillers and Diluents
• MCC
• Coating Agent
• Crosspovidone
• Flavoring Agent
• HPMC
• Croscarmellose
• Lubricants
• Others
• HPC

Nutraceutical Excipients Market segmented by Dosage Form:

• Tablets
• Capsules
• Gummies and Chewables
• Powders and Sachets
• Softgels
• Liquids

Nutraceutical Excipients Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• USA Food and Drug Administration (2025, January 15). FDA to Revoke Authorization for the Use of Red No. 3 in Food and Ingested Drugs.
• USA Food and Drug Administration (2025, July 14). FDA Encourages Food Manufacturers to Accelerate Phasing Out the Use of FD&C Red No. 3 in Foods Before 2027 Deadline.
• Food Standards Agency (2026, June 25). Food supplements guidance.
• Consumer Affairs Agency, Japan (2025, October 1). Revised guidance for Foods with Function Claims notifications and related requirements.
• Ministry of Food and Drug Safety, South Korea (2026, August 13). Regulation on Recognition of Functional Ingredient and of Standard and Specification for Health Functional Foods (No. 2026-33).
• Ministry of Food and Drug Safety, South Korea (2026, August 19). Revised comprehensive guide to personalized health functional food legislation and systems.
• European Commission (accessed September 2026). Food Additives Database.
• Roquette (2025, May 1). Roquette Completes the Acquisition of IFF Pharma Solutions.
• Roquette (2025, October 14). Roquette Marks New Chapter at CPHI 2025 After Key Acquisitions.
• Roquette (2026, April 28). Showcasing Consumer Healthcare Capabilities at Vitafoods Europe 2026.
• JRS Pharma (accessed September 2026). Excipients Product Overview.
• JRS Pharma (accessed September 2026). PROSOLV NX high-functionality excipient composite for direct-compression nutraceutical applications.
• Ashland Inc. (2026, June 3). Ashland Life Sciences strengthens presence in Asia Pacific with strategic investment in Aquarius tablet coatings manufacturing facility.
• Colorcon Inc. (2025, July 24). Colorcon Celebrates Grand Opening of New Manufacturing Facility in Malaysia.
• Colorcon Inc. (accessed September 2026). Nutrafinish Coating Systems for nutritional and dietary supplement products.
• International Flavors & Fragrances Inc. (2026, March 9). Behind the Scenes of Taste Modulation: Principal Scientist Diana Klaser Cheng.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• How large is the nutraceutical excipients market in 2026 and what value is forecast for 2036?
• Which formulation and regulatory pressures create demand for nutraceutical excipients?
• Why do Fillers and Diluents lead the Product Type category?
• How do excipient requirements change across Tablets, Capsules, Gummies and Chewables, Powders and Sachets, Softgels, and Liquids?
• How do forecast growth rates differ across the profiled countries?
• Which companies participate in core excipients, coatings, and sensory formulation?
• What limits supplier substitution and the conversion of formulation trials into repeat orders?
• What should buyers evaluate before qualifying an excipient for a nutraceutical dosage form?